Lipodermatosclerosis: Successful treatment with danazol [11]

Acta Dermato-Venereologica

Volumn 85, Issue 4, 2005, Pages 365-366

  Hafner, Christian ^a   Wimmershoff, Monika ^a   Landthaler, Michael ^a   Vogt, Thomas ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DANAZOL;

AGED; CASE REPORT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; LEG; LETTER; LIPODERMATOSCLEROSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SKIN BIOPSY;

ADMINISTRATION, ORAL; AGED; DANAZOL; DIAGNOSIS, DIFFERENTIAL; ESTROGEN ANTAGONISTS; HUMANS; LEG DERMATOSES; MALE; SCLERODERMA, LOCALIZED;

EID: 23444456148     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550510027766     Document Type: Letter

References (10)

1. LeBlanc N, Falabella A, Murata H, Hasan A, Weiss E, Falanga V. Durometer measurements of skin induration in venous disease. Dermatol Surg 1997; 23: 285-287.
2. Nemeth AJ, Eaglstein WH, Falanga V. Clinical parameters and transcutaneous oxygen measurements for the prognosis of venous ulcers. J Am Acad Dermatol 1989; 20: 186-190.
3. Bruce AJ, Bennett DD, Lohse CM, Rooke TW, Davis MD. Lipodermatosclerosis: review of cases evaluated at Mayo Clinic. J Am Acad Dermatol 2002; 46: 187-192.
4. Kirsner RS, Pardes JB, Eaglstein WH, Falanga V. The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol 1993; 28: 623-627.
5. Greenberg AS, Hasan A, Montalvo BM, Falabella A, Falanga V. Acute lipodermatosclerosis is associated with venous insufficiency. J Am Acad Dermatol 1996; 35: 566-568.
6. Ahnlide I, Bjellerup M, Akesson H. Excision of lipodermatosclerotic tissue: an effective treatment for non-healing venous ulcers. Acta Derm Venereol 2000; 80: 28-30.
7. Samlaska CP, Winfield EA. Pentoxifylline. J Am Acad Dermatol 1994; 30: 603-621.
8. Helfman T, Falanga V. Stanozolol as a novel therapeutic agent in dermatology. J Am Acad Dermatol 1995; 33: 254-258.
9. Jenkin G. Review: The mechanism of action of danazol, a novel steroid derivative. Aust N Z J Obstet Gynaecol 1980; 20: 113-118.
10. Crook D, Sidhu M, Seed M, O'Donnell M, Stevenson JC. Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid. Atherosclerosis 1992; 92: 41-47.